PUBLISHER: The Business Research Company | PRODUCT CODE: 1664613
PUBLISHER: The Business Research Company | PRODUCT CODE: 1664613
Point of care (POC) diagnostics involves medical testing conducted at or near the location of patient care, providing fast and accurate results to guide immediate patient care decisions.
The primary product types in point of care diagnostics include glucose monitoring kits, infectious diseases testing kits, pregnancy and fertility testing kits, hematology testing kits, cardiometabolic monitoring kits, urinalysis testing kits, cholesterol test strips, and others. Glucose monitoring kits are medical devices designed to measure the levels of glucose (sugar) in a person's blood. They are available as both over-the-counter (OTC) devices and prescription-based devices, catering to various end-users such as professional diagnostic centers, research laboratories, home care settings, and others.
The point of care diagnostics market research report is one of a series of new reports from The Business Research Company that provides point of care diagnostics optical components market statistics, including point of care diagnostics optical components industry global market size, regional shares, competitors with a point of care diagnostics optical components market share, detailed point of care diagnostics optical components market segments, market trends and opportunities, and any further data you may need to thrive in the point of care diagnostics optical components industry. This point of care diagnostics optical components market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The point of care diagnostics market size has grown strongly in recent years. It will grow from $48.06 billion in 2024 to $51.76 billion in 2025 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to rise of chronic diseases, diagnostic accuracy improvements, shift in healthcare setting, healthcare cost pressures, consumer demand for convenience.
The point of care diagnostics market size is expected to see strong growth in the next few years. It will grow to $74.15 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to remote healthcare needs, market expansion in emerging economies, personalized healthcare, focus on preventive healthcare, investment in research & development. Major trends in the forecast period include rise of personalized medicine, technological miniaturization, telemedicine integration, emergence of novel biomarkers, consumer empowerment.
The rising incidence of chronic and infectious diseases is propelling the point-of-care (POC) diagnostics market. Chronic diseases are conditions that develop gradually over time and typically last three months or longer. POC diagnostics play a crucial role in the effective management of chronic diseases and are widely utilized due to their convenience. For example, in 2023, the Centers for Disease Control and Prevention (CDC) reported that 42% of adults in the U.S. were living with two or more chronic conditions. This trend raises concerns as it underscores the increasing prevalence of multiple chronic diseases among the adult population. Consequently, the growing prevalence of chronic diseases is driving the expansion of the point-of-care (POC) diagnostics market.
The point-of-care (POC) diagnostics market is set to experience growth propelled by the rising demand for at-home testing. At-home testing involves self-sample collection and testing using over-the-counter or online kits/devices. Point-of-care (POC) diagnostics play a pivotal role in at-home testing, allowing individuals to conveniently monitor their health status. A survey conducted in December 2022 revealed that approximately 25% of consumers demand at-home testing, with 21% finding it convenient. This increasing preference for at-home testing is a significant contributor to the expanding point-of-care (POC) diagnostics market.
Innovation is a prominent trend in the point-of-care (POC) diagnostics market, with major companies introducing novel products to maintain their market position. For instance, PocDoc, a US-based diagnostics company, launched the PocDoc Cardiovascular Diseases point-of-care test in January 2022. This innovative product stands out as the world's first smartphone-based test for cardiovascular disease, offering users a five-step process, including sample collection, lateral flow test kit usage, and instant diagnosis on their smartphones.
Key players in the point-of-care (POC) diagnostics market are concentrating on technological innovations, such as rapid PCR systems, to secure a competitive advantage. A rapid PCR system is a type of polymerase chain reaction (PCR) test that delivers results faster than traditional PCR tests. For example, in January 2023, Cipla, a pharmaceutical company based in India, introduced its point-of-care testing device named Cippoint. This innovative device is designed to provide quick and accurate diagnostic results for a variety of health conditions. The Cippoint platform is compact, user-friendly, and adaptable for use in various settings, including hospitals and clinics. It utilizes advanced technology that allows healthcare professionals to conduct tests efficiently and effectively.
In July 2024, Roche, a pharmaceutical company based in Switzerland, acquired LumiraDx's point-of-care technology for an undisclosed sum. This strategic acquisition is intended to improve Roche's access to diagnostic testing in primary care environments. LumiraDx, a company located in the U.S., specializes in innovative point-of-care diagnostic solutions.
Major companies operating in the point of care diagnostics market include Abbott Laboratories, Siemens Healthineers AG, Beckman Coulter Inc., Becton, Dickinson and Company, Instrumentation Laboratory Company, Nova Biomedical Corporation, Qiagen NV, F. Hoffmann-La Roche Ltd., Biomeriux SA, Quidel Corporation, Orasure Technologies Inc., Johnson and Johnson, Thermo Fisher Scientific Inc., Sysmex corporation, Sinocare Inc., Arkray Inc., Danaher Corporation, Chembio Diagnostics Inc., EKF Diagnostics Holdings plc, Trinity Biotech plc, Fluxergy Inc., LumiraDx UK Ltd., Meridian Bioscience Inc., Nipro Europe Group Companies, AccuBioTech Co. Ltd., Atlas Genetics Ltd., Atlas Link Biotech Co. Ltd., Biomeme Inc., Cepheid Inc., Church & Dwight Co. Inc.
North America was the largest region in the point of care diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the point of care diagnostics market report during the forecast period. The regions covered in the point of care diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the point of care diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The point of care (POC) diagnostics market consists of sales of blood glucose meters, pregnancy test kits, and cardiac markers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Point of Care Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on point of care diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for point of care diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The point of care diagnostics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.